更正：用于蛋白尿管理的尿蛋白：肌酐比值与24小时尿蛋白对比：来自乐伐替尼与索拉非尼治疗肝细胞癌的3期REFLECT研究的分析
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
作者信息
Evans Thomas R Jeffry, Kudo Masatoshi, Finn Richard S, Han Kwang-Hyub, Cheng Ann-Lii, Ikeda Masafumi, Kraljevic Silvija, Ren Min, Dutcus Corina E, Piscaglia Fabio, Sung Max W
机构信息
University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
出版信息
Br J Cancer. 2019 Oct;121(7):625. doi: 10.1038/s41416-019-0534-2.
This article was originally published under a standard license to Publish, but has now been made available under a CC BY license. The PDF and HTML versions of the paper have been modified accordingly.An amendment to this paper has been published and can be accessed via a link at the top of the paper.
本文最初根据标准出版许可发布，但现在已根据知识共享署名许可提供。论文的PDF和HTML版本已相应修改。本文的一项修正案已发表，可通过论文顶部的链接访问。
Zotero 插件